title: Can influenza H1N1 vaccination lead to the membranous glomerulonephritis?
abstract: In 2009 winter, Influenza A (H1N1) monovalent split virus vaccine was used prevalently in the whole world as a result of the pandemic caused by Influenza (H1N1) virus. The vaccine's adverse effects were observed closely and vaccination has been found as safe in most studies. But some reports about immune response related diseases after influenza vaccinations are remarkable. The close relationship between membranous glomerulonephritis and antigens is known, particularly in seconder forms which occur after viral infections and vaccinations. So this case report is about a 56-year-old man, who developed membranous glomerulonephritis 23 days after the vaccination against Influenza A (H1N1) virus.
authors: Department of Infectious Diseases, Duzce University, Faculty of Medicine, Duzce, Turkey.
authors: Ali
authors: A
authors: Kutlucan
authors: Ibak
authors: I
authors: Gonen
authors: Esra
authors: E
authors: Yildizhan
authors: Yusuf
authors: Y
authors: Aydin
authors: Tansu
authors: T
authors: Sav
authors: Umran
authors: U
authors: Yildirim
mesh_terms: D015433:Glomerulonephritis, Membranous / Q000139:chemically induced*; D006651:Histocytochemistry; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D007251:Influenza, Human / Q000517:prevention & control / Q000821:virology; D007668:Kidney / Q000473:pathology; D008297:Male; D008853:Microscopy; D008875:Middle Aged; D014611:Vaccination / Q000009:adverse effects*
chemical_list: D007252:Influenza Vaccines